Why Have Drug Names Become So Weird? A Retrospective Analysis of the Orthographic Distinctiveness of Proprietary and Generic Names Across Four Decades of FDA Approvals

Bruce L. Lambert

Open source

DOI
10.64898/2026.10.15.26365645
Published
2026-10-16
Container
Not recorded
Publisher
openRxiv
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.10.15.26365645,
  title = {Why Have Drug Names Become So Weird? A Retrospective Analysis of the Orthographic Distinctiveness of Proprietary and Generic Names Across Four Decades of FDA Approvals},
  author = {Bruce L. Lambert},
  year = {2026},
  doi = {10.64898/2026.10.15.26365645},
  url = {https://doi.org/10.64898/2026.10.15.26365645}
}

RIS

TY  - JOUR
TI  - Why Have Drug Names Become So Weird? A Retrospective Analysis of the Orthographic Distinctiveness of Proprietary and Generic Names Across Four Decades of FDA Approvals
AU  - Bruce L. Lambert
PY  - 2026
DO  - 10.64898/2026.10.15.26365645
UR  - https://doi.org/10.64898/2026.10.15.26365645
ER  - 

APA

Lambert, B. L. (2026). Why Have Drug Names Become So Weird? A Retrospective Analysis of the Orthographic Distinctiveness of Proprietary and Generic Names Across Four Decades of FDA Approvals. https://doi.org/10.64898/2026.10.15.26365645

Source records